At 7.1% CAGR, Ocular Implant Market to Surpass US$ 20.2 Billion by 2027 | Growing Business of Implants in Upcoming Years

The latest research report provides a complete analysis of the Global Ocular Implant Market for the forecast year 2020-2027, which is beneficial for companies regardless of their size and revenue. This survey report covering the major market insights and industry approach towards COVID-19 in the upcoming years. The market strategies undertaken, with respect to the current and future scenario of the industry, have also been listed in the study.

Request a sample copy @
https://www.coherentmarketinsights.com/insight/request-sample/2699

Increasing product launches for different types ocular implants that are widely used in ophthalmic surgery to correct ophthalmic deformities is expected to drive global ocular implant market growth. For instance, in February 2019, EyePoint Pharmaceuticals, Inc. launched its YUTIQ in the U.S. YUTIQ is three-year intravitreal micro-insert for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye. The product was approved by U.S. FDA in October 2018.

Moreover, increasing prevalence of ocular dysfunction and disorder is expected to drive growth of the global ocular implant market. For instance, in January 2019, according to Glaucoma research foundation, currently, there are over 3 million people in the U.S. that have been diagnosed with glaucoma. The National Eye Institute projects that this number will be increased by 58% and expected to reach 4.2 million by 2030.

Increasing number of research and development activities to develop innovative ocular implant is contributing to growth of global ocular implant market. For instance, in July 2018, Genentech, Inc. announced positive results for Phase II clinical trial study conducted to evaluate the safety and efficacy of the investigational Port Delivery System (PDS) with Ranibizumab, the first-ever eye implant to achieve sustained delivery of a biologic medicine, in people with wet age-related macular degeneration (AMD)

PDF Brochure Of This Report @
https://www.coherentmarketinsights.com/insight/request-pdf/2699

Development of innovative ocular implants and rising approvals from regulatory authorities for ocular implants and prosthetics is expected to drive growth of global ocular implant market. For instance, in July 2016, Abbott received U.S. Food and Drug Administration (FDA) approval for its Tecnis Symfony Intraocular Lenses, indicated for the treatment of cataracts. This FDA approval includes a version of the lens for people with astigmatism, the Tecnis Symfony Toric IOL. Moreover, in March 2019, Implandata Ophthalmic Products GmbH (Implandata) received CE marking for its next generation EYEMATE-IO 1.1 implantable micro-sensor.

Apply Promo Code “STAYHOME” and Get FLAT 20% Discount

Buy This Complete A Business Report:
https://www.coherentmarketinsights.com/insight/buy-now/2699

Detailed Segmentation:

Global Ocular Implant Market, By Implant Type
Intraocular Lenses (IOL)
Aspheric IOLs
Toric IOLs
Multifocal IOLs
Anterior chamber IOLs
Others
Corneal Implants
Glaucoma Implants
Orbital Implants
Ocular prosthesis
Others
Global Ocular Implant Market, By Application:
Glaucoma Surgery
Oculoplasty
Drug Delivery
Age-Related Macular Degeneration (AMD)
Aesthetic purpose
Others

Read Detailed Index of full Research Study at: https://www.coherentmarketinsights.com/market-insight/ocular-implant-market-2699

Coherent Market Insights 1001 4th Ave,
#3200 Seattle, WA 98154,U.S.
Phone: US +1-206-701-6702/UK +44-020 8133 4027
Email: sales@coherentmarketinsights.com

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.